Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Research Outputs
  • Researchers
  • Organizations
  • Projects
  • Explore by
    • Research Outputs
    • Researchers
    • Organizations
    • Projects
  • Communities & Collections
  • SDGs
  • Sign in
  • 中文
  • English
  1. National Taiwan Ocean University Research Hub
  2. Research Outputs

Browsing by Author Maritime Development and Training Center


Jump to:
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 51 to 70 of 164 < previous   next >
Issue DateTitleAuthor(s)SourceWOSFulltext/Archive link
2017Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesCedeno-Laurent, F.; Wysocka, M.; Obstfeld, A. E.; Novoa, R. A.; Vittorio, C. C.; Kim, E. J.; Wen-Kai Weng ; Rook, A. H.Journal of Cutaneous Pathology
2005Genetic polymorphism of the inhibitory IgG Fc receptor Fc gamma RIIb is not associated with clinical outcome of rituximab treated follicular lymphoma patientsWen-Kai Weng ; Levy, R.Blood
2009Genetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximabWen-Kai Weng ; Levy, R.Leukemia & Lymphoma
2015Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2Ungewickell, A.; Bhaduri, A.; Rios, E.; Reuter, J.; Lee, C. S.; Mah, A.; Zehnder, A.; Ohgami, R.; Kulkarni, S.; Armstrong, R.; Wen-Kai Weng ; Gratzinger, D.; Tavallaee, M.; Rook, A.; Snyder, M.; Kim, Y.; Khavari, P. A.Nature Genetics
2012Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS)Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H.Journal of Investigative Dermatology
2011Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary SyndromeWen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H.Blood
2018Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)Gupta, R.; Albabtain, A.; Arai, S.; Kwong, B.; Wen-Kai Weng Blood
2017Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit LymphomaChoi, T.; Kodali, M. K.; Wen-Kai Weng Biology of Blood and Marrow Transplantation
2003Hepatitis C virus (HCV) and lymphomagenesisWen-Kai Weng ; Levy, S.Leukemia & Lymphoma
2002High-efficiency white organic light-emitting devices with dual doped structureHuang, Y. S.; Jou, J. H.; Wen-Kai Weng ; Liu, J. M.Applied Physics Letters
2012The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patientsKelly-Sell, M. J.; Kim, Y. H.; Straus, S.; Benoit, B.; Harrison, C.; Sutherland, K.; Armstrong, R.; Wen-Kai Weng ; Showe, L. C.; Wysocka, M.; Rook, A. H.American Journal of Hematology
2017HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activitySpinner, M. A.; Fernandez-Vina, M.; Creary, L. E.; Quinn, O.; Elder, L.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Shizuru, J. A.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R.Blood Advances
2001Human anti-CD40 antagonistic antibodies, inhibit the proliferation of human B cell non-Hodgkin's lymphomaWen-Kai Weng ; Wang, C. Y.; Chu, K. T.; Levy, R.Blood
2005Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapyWen-Kai Weng ; Czerwinski, D.; Levy, R.Blood
2007Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphorna patients regardless of their response to induction chemotherapyWen-Kai Weng ; Czerwinski, D.; Levy, R.Blood
2010Immunoglobulin G Fc Receptor Fc gamma RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's LymphomaWen-Kai Weng ; Negrin, R. S.; Lavori, P.; Horning, S. J.Journal of Clinical Oncology
2004Immunoglobulin G Fc receptor polymorphisms and clinical course in follicular lymphoma patientsWen-Kai Weng ; Rosenberg, A.; Levy, R.Blood
2009Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphomaWen-Kai Weng ; Levy, R.Leukemia & Lymphoma
2011Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary ResultsBrody, J. D.; Czerwinski, D. K.; Carlton, V.; Moorhead, M.; Zheng, J. B. A.; Klinger, M.; Faham, M.; Advani, R.; Kohrt, H. E.; Alizadeh, A. A.; Negrin, R. S.; Weng, WK ; Sheehan, K.; Levy, R.Blood0
2018Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantationMuffly, L.; Sheehan, K.; Armstrong, R.; Jensen, K.; Tate, K.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R.Blood Advances
Showing results 51 to 70 of 164 < previous   next >
Explore by
  • Communities & Collections
  • Research Outputs
  • Researchers
  • Organizations
  • Projects
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback